BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

NCT01241331 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
233
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Braintree Laboratories